Asr Vermogensbeheer N.V. Natera, Inc. Transaction History
Asr Vermogensbeheer N.V.
- $7.71 Trillion
- Q2 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Natera, Inc. stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 12,374 shares of NTRA stock, worth $1.73 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,374
Previous 1,716
621.1%
Holding current value
$1.73 Million
Previous $243 Million
761.43%
% of portfolio
0.03%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NTRA
# of Institutions
655Shares Held
126MCall Options Held
975KPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.73 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.47 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.03 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$947 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$636 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $13.6B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...